Important Announcement Regarding Weight Loss
- Dr. Desmond Foo, MD
- Apr 1
- 2 min read
At Aloha Aesthetics MD, we remain dedicated to providing you with safe and effective weight loss and wellness solutions. In light of recent developments surrounding compounded Tirzepatide (commonly found in Mounjaro or Zepbound), we want to clarify our position and assure our patients of our commitment to compliant patient care. Patients in our care receiving "brand name" Mounjaro or Zepbound medications will not be affected.
1. Commercially Available Doses of Compounded Tirzepatide
Please note that we have phased out offering specific formulations that are essential "copies" of the patented and commercially available Tirzepatide medications. These are single-dose pens that come in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses or single-dose vials of 2.5 mg, 5 mg, 7.5 mg and 10 mg. This decision aligns with regulations designed to protect both patients and healthcare providers from legal challenges associated with the manufacturer’s patent rights.
2. Personalized Dosing Regimens
Should you be prescribed a personalized Tirzepatide regimen tailored to your individual medical needs, we will continue to provide therapy without interruption. Our team remains dedicated to working within legally permissible pathways to ensure the highest quality care.
Alternatives for Your Weight Loss Journey
We value your trust and are committed to supporting you in achieving your health goals. If this announcement affects you, we encourage you to speak with our care team to discuss suitable alternatives and explore other treatment options to help you continue on your wellness path.We appreciate your understanding and look forward to providing guidance on a plan that best meets your needs. If you have questions or require further assistance, please contact our clinical team.
Aloha Aesthetics MD
Comments